BLI Banque de Luxembourg Investments Buys New Shares in Exponent, Inc. (NASDAQ:EXPO)

BLI Banque de Luxembourg Investments bought a new position in Exponent, Inc. (NASDAQ:EXPO - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 141,300 shares of the business services provider's stock, valued at approximately $12,564,000. BLI Banque de Luxembourg Investments owned about 0.28% of Exponent as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the company. Barclays PLC lifted its position in Exponent by 219.0% in the 3rd quarter. Barclays PLC now owns 96,526 shares of the business services provider's stock valued at $11,127,000 after acquiring an additional 66,263 shares in the last quarter. Anchor Investment Management LLC purchased a new stake in shares of Exponent during the third quarter valued at $64,000. JPMorgan Chase & Co. increased its holdings in Exponent by 63.6% in the 3rd quarter. JPMorgan Chase & Co. now owns 630,644 shares of the business services provider's stock worth $72,701,000 after buying an additional 245,086 shares in the last quarter. Argent Capital Management LLC raised its position in Exponent by 17.3% in the 4th quarter. Argent Capital Management LLC now owns 28,323 shares of the business services provider's stock worth $2,524,000 after buying an additional 4,173 shares during the last quarter. Finally, Heritage Family Offices LLP lifted its stake in Exponent by 3.8% during the 4th quarter. Heritage Family Offices LLP now owns 3,123 shares of the business services provider's stock valued at $278,000 after acquiring an additional 114 shares during the period. Institutional investors own 92.37% of the company's stock.

Insider Buying and Selling

In other Exponent news, VP Richard Reiss sold 1,736 shares of the company's stock in a transaction dated Wednesday, February 26th. The stock was sold at an average price of $85.93, for a total value of $149,174.48. Following the completion of the sale, the vice president now owns 1,800 shares in the company, valued at $154,674. This represents a 49.10 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. 2.10% of the stock is currently owned by insiders.

Exponent Stock Performance

Shares of EXPO stock traded down $0.33 during trading hours on Wednesday, reaching $74.86. The company had a trading volume of 232,661 shares, compared to its average volume of 242,354. The business has a fifty day moving average price of $80.18 and a 200-day moving average price of $89.14. Exponent, Inc. has a one year low of $73.37 and a one year high of $115.75. The firm has a market cap of $3.80 billion, a PE ratio of 35.31 and a beta of 0.95.

Exponent (NASDAQ:EXPO - Get Free Report) last announced its earnings results on Thursday, May 1st. The business services provider reported $0.52 earnings per share for the quarter, beating analysts' consensus estimates of $0.48 by $0.04. The business had revenue of $137.44 million during the quarter, compared to analyst estimates of $134.63 million. Exponent had a net margin of 19.52% and a return on equity of 27.27%. The company's quarterly revenue was up .2% compared to the same quarter last year. During the same period in the previous year, the business earned $0.59 EPS. Equities research analysts forecast that Exponent, Inc. will post 1.98 EPS for the current year.

Exponent Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, June 20th. Shareholders of record on Friday, June 6th will be issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 1.60%. The ex-dividend date of this dividend is Friday, June 6th. Exponent's dividend payout ratio is 58.54%.

Exponent Company Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.